Role of the Adipocyte, Free Fatty Acids, and Ectopic Fat in Pathogenesis of Type 2 Diabetes Mellitus: Peroxisomal Proliferator-Activated Receptor Agonists Provide a Rational Therapeutic Approach

Cited by (662)

Items 201–300 of 662

1. Adipophilin distribution and colocalisation with lipid droplets in skeletal muscle
   Christopher S. Shaw, Mark Sherlock, Paul M. Stewart, Anton J. M. Wagenmakers · 2009 · Histochemistry and Cell Biology
2. Targeting the kidney and glucose excretion with dapagliflozin: preclinical and clinical evidence for SGLT2 inhibition as a new option for treatment of type 2 diabetes mellitus
   J. Whaley, M. Tirmenstein, T. Reilly, S. M. Poucher, J. Saye, S. Parikh, J. List · 2012 · Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
3. Type 2 diabetes and obesity in adults
   Whitmore, Catherine · 2010 · British Journal of Nursing
4. A Twenty-First Century Cancer Epidemic Caused by Obesity: The Involvement of Insulin, Diabetes, and Insulin-Like Growth Factors
   Rosalyne Westley, Felicity E. B. May · 2013 · International Journal of Endocrinology
5. Type 2 Diabetes Mellitus-Induced Hyperglycemia in Patients with NAFLD and Normal LFTs: Relationship to Lipid Profile, Oxidative Stress and Pro-Inflammatory Cytokines
   Mohamed E. E. Shams · 2011 · Scientia Pharmaceutica
6. Vitamin E and adiponectin: proposed mechanism for vitamin E-induced improvement in insulin sensitivity
   Brianna E Gray, Jennifer Swick, Alayne G. Ronnenberg · 2011 · Nutrition Reviews
7. Early changes in insulin secretion and action induced by high-fat diet are related to a decreased sympathetic tone
   Céline Cruciani‐Guglielmacci, M. Vincent-Lamon, Claude Rouch, Martine Orosco, Alain Ktorza, Chr̀istophe Magnan · 2004 · American Journal of Physiology-Endocrinology and Metabolism
8. Nonalcoholic fatty liver disease: The hepatic trigger of the metabolic syndrome
   Federico Salomone, Elisabetta Bugianesi · 2010 · Journal of Hepatology
9. Mango modulates body fat and plasma glucose and lipids in mice fed a high-fat diet
   Edralin A. Lucas, Wenjia Li, Sandra Peterson, Angela Brown, Solo R. Kuvibidila, Penelope M. Perkins-Veazie, Stephen L. Clarke, Brenda Jane Smith · 2011 · British Journal Of Nutrition
10. Association between variants in the genes for adiponectin and its receptors with insulin resistance syndrome (IRS)-related phenotypes in Mexican Americans
    Dawn K. Richardson, Jennifer L. Schneider, Marcel J. Fourcaudot, Lenore M. Rodriguez, Rector Arya, Thomas D. Dyer, Laura A. Almasy, John Blangero, Michael P. Stern M. D, Ralph A. DeFronzo et al. · 2006 · Diabetologia
11. Integrated lipidomics and transcriptomic analysis of peripheral blood reveals significantly enriched pathways in type 2 diabetes mellitus
    Chen Zhao, Jinghe Mao, Junmei Ai, Ming Shenwu, Tieliu Shi, Daqing Zhang, Xiaonan Wang, Yunliang Wang, Youping Deng · 2013 · BMC Medical Genomics
12. Sweet tea leaves extract improves leptin resistance in diet-induced obese rats
    Cai-Jie Zhou, Song Mei Huang, Jiang‐Qi Liu, Shu-Qi Qiu, Fang-Yi Xie, Hou-pan Song, Yisheng Li, Shaozhen Hou, Xiao‐Ping Lai · 2012 · Journal of Ethnopharmacology
13. Hypoglycemic Effects and Biochemical Mechanisms of Oat Products on Streptozotocin-Induced Diabetic Mice
    Ruiling Shen, Fengli Cai, Jilin Dong, Xinzhong Hu · 2011 · Journal of Agricultural and Food Chemistry
14. Developmental Programming: Differential Effects of Prenatal Testosterone Excess on Insulin Target Tissues
    Shadia E. Nada, Robert C. Thompson, Vasantha Padmanabhan · 2010 · Endocrinology
15. Benefits and risks of the treatment with fibrates––a comprehensive summary
    Bogusław Okopień, Łukasz Bułdak, Aleksandra Bołdys · 2018 · Expert Review of Clinical Pharmacology
16. Potential Antidiabetic Fumiquinazoline Alkaloids from the Marine-Derived Fungus Scedosporium apiospermum F41‑1
    Chanjuan Li, Pei-Nan Chen, Hou‐Jin Li, Taifo Mahmud, Dong-Lan Wu, Jun Xu, Wen‐Jian Lan · 2020 · Journal of Natural Products
17. Redefining the role of thiazolidinediones in the management of type 2 diabetes
    Barnett · 2009 · Vascular Health and Risk Management
18. Crocetin attenuates palmitate‐induced insulin insensitivity and disordered tumor necrosis factor‐α and adiponectin expression in rat adipocytes
    L Xi, Zhiyu Qian, Guanglin Xu, Chenghua Zhou, Sai Sun · 2007 · British Journal of Pharmacology
19. Adiposopathy and bariatric surgery: is ‘sick fat’ a surgical disease?
    H. Bays, B. Laferrère, J. Dixon, L. Aronne, J. González-Campoy, C. Apovian, B. Wolfe · 2009 · International journal of clinical practice
20. Does Parkinson’s Disease and Type-2 Diabetes Mellitus Present Common Pathophysiological Mechanisms and Treatments?
    Marcelo M. S. Lima, Adriano Targa, Ana Carolina D. Noseda, Laís Soares Rodrigues, Ana Márcia Delattre, Fabiola Vila dos Santos, Mariana Fortes, Maira J. Maturana, Anete Curte Ferraz · 2014 · CNS & Neurological Disorders - Drug Targets
21. Identification of genes in longissimus dorsi muscle differentially expressed between Wannanhua and Yorkshire pigs using RNA ‐sequencing
    X.‐J. Li, Jie Zhou, L.‐Q. Liu, K. Qian, Chung‐Li Wang · 2016 · Animal Genetics
22. Adiposopathy is a more rational treatment target for metabolic disease than obesity alone
    H. Bays, C. Dujovne · 2006 · Current Atherosclerosis Reports
23. Metformin and pioglitazone: effectively treating insulin resistance
    Bart Staels · 2006 · Current Medical Research and Opinion
24. Association of insulin resistance with hyperglycemia in streptozotocin-diabetic pigs
    S.J. Koopmans, Z. Mroz, R.A. Dekker, Henk Corbijn, Mariëtte T. Ackermans, Hans P. Sauerwein · 2006 · Metabolism
25. Type 2 Diabetes, PUFAs, and Vitamin D: Their Relation to Inflammation
    Ana Laura Guadarrama López, Roxana Valdés‐Ramos, Beatriz Elina Martínez‐Carrillo · 2014 · Journal of Immunology Research
26. Antilipolytic Activity of a Novel Partial A1 Adenosine Receptor Agonist Devoid of Cardiovascular Effects: Comparison with Nicotinic Acid
    Arvinder K. Dhalla, Melissa Santikul, Michelle G. Smith, Mei-Yee Wong, John C. Shryock, Luiz Belardinelli · 2007 · Journal of Pharmacology and Experimental Therapeutics
27. Treatment with exenatide once weekly or twice daily for 30 weeks is associated with changes in several cardiovascular risk markers
    Steven C. Brunell, Peter Paul Toth, Gilbert Ramı́rez, Cobble, Chilton, Chiquette · 2012 · Vascular Health and Risk Management
28. Strong association between insulin resistance in liver and skeletal muscle in non‐diabetic subjects
    Muhammad A Abdul‐Ghani, Masafumi Matsuda, Ralph A. DeFronzo · 2008 · Diabetic Medicine
29. Conjugated linoleic acid does not reduce body fat but decreases hepatic steatosis in adult Wistar rats
    Aparna Purushotham, Gayle E. Shrode, Angela A. Wendel, Li-Fen Liu, Martha Ann Belury · 2007 · The Journal of Nutritional Biochemistry
30. A double-blind, randomised trial of tesaglitazar versus pioglitazone in patients with type 2 diabetes mellitus
    Harold Edward Bays, Jennifer McElhattan, Brian S. Bryzinski · 2007 · Diabetes and Vascular Disease Research
31. Hypertension in Patients with Insulin Resistance: Etiopathogenesis and Management in Children
    Veronica Maria Tagi, Francesca Mainieri, Francesco Chiarelli · 2022 · International Journal of Molecular Sciences
32. Effect of Dapagliflozin With and Without Acipimox on Insulin Sensitivity and Insulin Secretion in T2DM Males
    Aurora Merovci, Muhammad A Abdul‐Ghani, Andrea Mari, Carolina Solis‐Herrera, Juan Xiong, Giuseppe Daniele, Devjit Tripathy, Ralph A. DeFronzo · 2016 · The Journal of Clinical Endocrinology & Metabolism
33. Pathophysiology of diabetes mellitus type 2: beyond the duo "insulin resistance-secretion deficit".
    C A Carrera Boada, José Manuel Martínez-Moreno · 2013 · PubMed
34. Can 14-3-3 proteins serve as therapeutic targets for the treatment of metabolic diseases?
    Kadidia Diallo, Abel K. Oppong, Gareth E. Lim · 2018 · Pharmacological Research
35. Fatty infiltration of the pancreas: a systematic concept analysis
    Mueataz A. Mahyoub, Mohamed Elhoumed, Abdulfatah Hassan Maqul, Maged Almezgagi, Mustafa A. Abbas, Yang Jiao, Jinhai Wang, Mohammed Alnaggar, Ping Zhao, Shuixiang He · 2023 · Frontiers in Medicine
36. Continual evolution of type 2 diabetes: an update on pathophysiology and emerging treatment options
    Susan A. Cornell · 2015 · Therapeutics and Clinical Risk Management
37. Spermidine is indispensable in differentiation of 3T3‐L1 fibroblasts to adipocytes
    Susanna Vuohelainen, Eija Pirinen, Marc Cerrada‐Gimenez, Tuomo A. Keinänen, Anne Uimari, Marko Pietilä, Alex R. Khomutov, Juhani Jänne, Leena I. Alhonen · 2009 · Journal of Cellular and Molecular Medicine
38. High free fatty acid level is associated with recurrent stroke in cardioembolic stroke patients
    Jeong‐Yoon Choi, Ji Sun Kim, Ji Hyun Kim, Kyungmi Oh, Seong‐Beom Koh, Woo‐Keun Seo · 2014 · Neurology
39. The Production of Nitric Oxide, IL-6, and TNF-Alpha in Palmitate-Stimulated PBMNCs Is Enhanced through Hyperglycemia in Diabetes
    Caroline Maria Oliveira Volpe, Luana Farnese Machado Abreu, Pollyanna Stephanie Gomes, Raquel Miranda Gonzaga, Clara Araújo Veloso, José Augusto Nogueira‐Machado · 2014 · Oxidative Medicine and Cellular Longevity
40. Oxidized LDL impair adipocyte response to insulin by activating serine/threonine kinases
    Beatrice Scazzocchio, Rosaria Varı́, Massimo D’Archivio, Carmela Santangelo, Carmelina Filesi, Claudio Giovannini, Roberta Masella · 2009 · Journal of Lipid Research
41. Wnt-signaling is maintained and adipogenesis inhibited by TNFα but not MCP-1 and resistin
    Ann Hammarstedt, Petter Isakson, Birgit Gustafson, Ulf Smith · 2007 · Biochemical and Biophysical Research Communications
42. Is insulin resistance atherogenic? Possible mechanisms
    Ralph Anthony DeFronzo · 2006 · Atherosclerosis Supplements
43. The Insulin Effect on Cerebrocortical Theta Activity Is Associated with Serum Concentrations of Saturated Nonesterified Fatty Acids
    Tschritter, Otto, Preissl, Hubert, Hennige, Anita M., Sartorius, Tina, Grichisch, Yuko, Stefan, Norbert, Guthoff, Martina, Düsing, Stephan, Machann, Jürgen, Schleicher, Erwin et al. · 2009 · The Journal of Clinical Endocrinology & Metabolism
44. A role of vitamin D in low-intensity chronic inflammation and insulin resistance in type 2 diabetes mellitus?
    Mario Flores · 2005 · Nutrition Research Reviews
45. Effects of bezafibrate on lipid and glucose metabolism in dyslipidemic patients with diabetes: the J-BENEFIT study
    Tamio Teramoto, Kohji Shirai, Hiroyuki Daida, Nobuhiro Yamada · 2012 · Cardiovascular Diabetology
46. Has natural selection in human populations produced two types of metabolic syndrome (with and without fatty liver)?
    Stephen Hugh Caldwell, Yoshihiro Ikura, Julia C. Iezzoni, Zhenqi Liu · 2007 · Journal of Gastroenterology and Hepatology
47. The citrus fruit flavonoid naringenin suppresses hepatic glucose production from Fao hepatoma cells
    Aparna Purushotham, Min Tian, Martha Ann Belury · 2008 · Molecular Nutrition & Food Research
48. The brain–adipose axis: A review of involvement of molecules
    Hiroyuki Shimizu, Masatomo Mori · 2005 · Nutritional Neuroscience
49. Role of lipid-derived mediators in skeletal muscle insulin resistance
    Taube, Annika, Eckardt, Kristin, Eckel, Juergen · 2009 · American Journal of Physiology-Endocrinology and Metabolism
50. Metabolic Basis of Ethnic Differences in Diabetes Risk in Overweight and Obese Youth
    Tanya L. Alderete, C. Toledo-Corral, M. Goran · 2014 · Current Diabetes Reports
51. Increased obesity resistance and insulin sensitivity in mice lacking the isocitrate dehydrogenase 2 gene
    Su Jeong Lee, Sung Hwan Kim, Kwon Moo Park, Jin Hyup Lee, Jeen‐Woo Park · 2016 · Free Radical Biology and Medicine
52. Lack of monoacylglycerol lipase prevents hepatic steatosis by favoring lipid storage in adipose tissue and intestinal malabsorption
    Matteo Tardelli, Francesca Virginia Bruschi, Thierry Claudel, Claudia Daniela Fuchs, Nicole Auer, Victoria Kunczer, Tatjana Stojaković, Hubert Scharnagl, Aı̈da Habib, Gernot F. Grabner et al. · 2019 · Journal of Lipid Research
53. Antidiabetic medications in overweight/obese patients with type 2 diabetes: drawbacks of current drugs and potential advantages of incretin-based treatment on body weight
    Enzo Bonora · 2007 · International Journal of Clinical Practice
54. Lorcaserin and adiposopathy: 5-HT2c agonism as a treatment for 'sick fat' and metabolic disease
    Bays, Harold E · 2009 · Expert Review of Cardiovascular Therapy
55. CEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH)
    Sonia Michael Najjar, Lucia Russo · 2013 · Seminars in Immunopathology
56. Animal Model of Gestational Diabetes Mellitus with Pathophysiological Resemblance to the Human Condition Induced by Multiple Factors (Nutritional, Pharmacological, and Stress) in Rats
    Siti Hajar Abdul Aziz, Cini Mathew John, Nur Intan Saidaah Mohamed Yusof, Massita Nordin, Rajesh Ramasamy, Aishah Adam, Fazlin Mohd Fauzi · 2016 · BioMed Research International
57. Low glycemic index diet reduces body fat and attenuates inflammatory and metabolic responses in patients with type 2 diabetes
    Júnia Maria Geraldo Gomes, Sabrina Pinheiro Fabrini, Rita de Cássia Gonçalves Alfenas · 2016 · Archives of Endocrinology and Metabolism
58. Combination Therapy With Exenatide Plus Pioglitazone Versus Basal/Bolus Insulin in Patients With Poorly Controlled Type 2 Diabetes on Sulfonylurea Plus Metformin: The Qatar Study
    Muhammad A Abdul‐Ghani, Osama Migahid, Ayman Megahed, John M. Adams, Curtis L. Triplitt, Ralph Anthony DeFronzo, Mahmoud Ali Zirie, Amin Jayyousi · 2017 · Diabetes Care
59. Crosstalk between Immune Cells and Adipocytes Requires Both Paracrine Factors and Cell Contact to Modify Cytokine Secretion
    Carolina Franco Nitta, Robert A. Orlando · 2013 · PLoS ONE
60. Acute Modulation of Adipose Tissue Lipolysis by Intravenous Estrogens
    Rachael E. Van Pelt, Wendolyn S. Gozansky, Robert Charles Hickner, Robert S. Schwartz, Wendy M. Kohrt · 2006 · Obesity
61. A New Transgenic Rat Model of Hepatic Steatosis and the Metabolic Syndrome
    Nathan Qi, Jiaming Wang, Václav Zı́dek, Vladimír Landa, Petr Mlejnek, Ludmila Kazdová, Michal Pravenec, Theodore W. Kurtz · 2005 · Hypertension
62. Biphasic Response of Mitochondrial Biogenesis to Oxidative Stress in Visceral Fat of Diet-Induced Obesity Mice
    Pei‐Wen Wang, Hsiao‐Mei Kuo, Hung‐Tu Huang, Alice Y. Chang, Shao‐Wen Weng, Ming‐Hong Tai, Jiin‐Haur Chuang, I‐Ya Chen, Shun‐Chen Huang, Tsu‐Kung Lin et al. · 2013 · Antioxidants and Redox Signaling
63. Epigenetic mechanisms in the pathogenesis of diabetic foot ulcers
    Haloom Rafehi, Assam El‐Osta, Tom C. Karagiannis · 2012 · Journal of Diabetes and its Complications
64. Effect of pioglitazone on body composition and bone density in subjects with prediabetes in the ACT NOW trial
    George A. Bray, Steven R. Smith, Mary Ann Banerji, Devjit Tripathy, S. Clément, Thomas A. Buchanan, Robert R. Henry, Abbas E. Kitabchi, Sunder Raj D. Mudaliar, Nicholas Musi et al. · 2013 · Diabetes Obesity and Metabolism
65. Adiposopathy, metabolic syndrome, quantum physics, general relativity, chaos and the Theory of Everything
    H. Bays · 2005 · Expert Review of Cardiovascular Therapy
66. Adiposopathy: treating pathogenic adipose tissue to reduce cardiovascular disease risk
    Bays, Harold, Rodbard, Helena W., Schorr, Alan Bruce, González-Campoy, J. Michael · 2007 · Current Treatment Options in Cardiovascular Medicine
67. Fish oil supplementation to rats fed high-fat diet during pregnancy prevents development of impaired insulin sensitivity in male adult offspring
    Benjamin B. Albert, Mark Hedley Vickers, Clint L. Gray, Clare M. Reynolds, Stephanie A. Segovia, José G. B. Derraik, Manohar L. Garg, David Cameron‐Smith, Paul Leslie Hofman, Wayne S. Cutfield · 2017 · Scientific Reports
68. The Insulin-Sensitizer Pioglitazone Remodels Adipose Tissue Phospholipids in Humans
    Palavicini, Juan P., Chavez-Velazquez, Alberto, Fourcaudot, Marcel, Tripathy, Devjit, Pan, Meixia, Norton, Luke, DeFronzo, Ralph A., Shannon, Christopher E. · 2021 · Frontiers in Physiology
69. NF-kB activation as a molecular basis of pathological process by metabolic syndrome
    IP Kaĭdashev · 2012 · Fìzìologìčnij žurnal
70. Petalonia improves glucose homeostasis in streptozotocin-induced diabetic mice
    Seong‐Il Kang, Young-Jun Jin, Hee‐Chul Ko, Soo‐Youn Choi, Joon‐Ho Hwang, Ilson Whang, Moo-Han Kim, Hye‐Sun Shin, Hyung-Bok Jeong, Se‐Jae Kim · 2008 · Biochemical and Biophysical Research Communications
71. Heart energy metabolism impairment in Western-diet induced obese mice
    Fabiana Alves Neves, Erika Afonso Costa Cortez, Amélia Faustino Bernardo, Ana Barbosa Marcondes de Mattos, Anatalia Kutianski Gonzalez Vieira, Tayanne de Oliveira Malafaia, Alessandra Alves Thole, Alessandra C. de S. Rodrigues-Cunha, Érica Patrícia Garcia‐Souza, Rosely Sichieri et al. · 2013 · The Journal of Nutritional Biochemistry
72. Plasma adiponectin distribution in a Mediterranean population and its association with cardiovascular risk factors and metabolic syndrome
    Jordi Salas‐Salvadó, Marisa Granada, Mònica Bulló, Augusto Corominas, Patricia Casas‐Agustench, Màrius Foz · 2007 · Metabolism
73. Implications of Rosiglitazone and Pioglitazone on Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus
    Brian K. Irons, Ronald Shane Greene, Timothy A. Mazzolini, Krystal L. Edwards, Rebecca B. Sleeper · 2006 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
74. Isomer-specific effects of CLA on gene expression in human adipose tissue depending on PPARγ2 P12A polymorphism: a double blind, randomized, controlled cross-over study
    Julia E. Herrmann, D Rubin, Robert Häsler, Ulf Helwig, M. Pfeuffer, Annegret Auinger, Christiane Laue, P Winkler, S Schreiber, D.E. BELL et al. · 2009 · Lipids in Health and Disease
75. Liraglutide ameliorates palmitate-induced insulin resistance through inhibiting the IRS-1 serine phosphorylation in mouse skeletal muscle cells
    Z. Li, Yi Zhu, C. Li, Yunzhao Tang, Zhenhuan Jiang, Ming Yang, Changlin Ni, D. Li, Liqun Chen, Wenyan Niu · 2018 · Journal of Endocrinological Investigation
76. NPY1R-targeted peptide-mediated delivery of a dual PPARα/γ agonist to adipocytes enhances adipogenesis and prevents diabetes progression
    Stefanie Wittrisch, Nora Klöting, Karin Mörl, Rima Chakaroun, Matthias Blüher, Annette Gabriele Beck‐Sickinger · 2019 · Molecular Metabolism
77. Pleiotropic Effects of Thiazolidinediones: Implications for the Treatment of Patients With Type 2 Diabetes Mellitus
    Ralph A. DeFronzo, Rucha J. Mehta, Joel J. Schnure · 2013 · Hospital Practice
78. Impaired subcutaneous adipocyte lipogenesis is associated with systemic insulin resistance and increased apolipoprotein B/AI ratio in men and women
    Johan Hoffstedt, David C. Forster, Patrik Löfgren · 2007 · Journal of Internal Medicine
79. Improving Efficacy of Diabetes Management Using Treatment Algorithms in a Mainly Hispanic Population
    Etta L. Fanning, Beatrice J. Selwyn, Anne C. Larme, Ralph Anthony DeFronzo · 2004 · Diabetes Care
80. Anti-diabesity middle eastern medicinal plants and their action mechanisms
    Saad, Bashar, Kmail, Abdalsalam, Haq, Sameena Z. H. · 2022 · Evidence-Based Complementary and Alternative Medicine
81. Pioglitazone reduces epicardial fat and improves diastolic function in patients with type 2 diabetes
    Alexander J. Moody, Marjorie Molina‐Wilkins, Geoffrey D. Clarke, Aurora Merovci, Carolina Solis‐Herrera, Eugênio Cersósimo, ROBERT J. CHILTON, Patricia Iozzo, Amalia Gastaldelli, Muhammad A Abdul‐Ghani et al. · 2022 · Diabetes Obesity and Metabolism
82. Dietary saturated fat/cholesterol, but not unsaturated fat or starch, induces C-reactive protein associated early atherosclerosis and ectopic fat deposition in diabetic pigs
    S.J. Koopmans, R.A. Dekker, Mariëtte T. Ackermans, Hans P. Sauerwein, Mireille J. M. Serlie, Heleen MM van Beusekom, Mieke van den Heuvel, Wim J. van der Giessen · 2011 · Cardiovascular Diabetology
83. Insulin Resistance: Pathophysiology and Rationale for Treatment
    Sergio Muntoni, Sandro Muntoni · 2011 · Annals of Nutrition and Metabolism
84. Reduced Basal ATP Synthetic Flux of Skeletal Muscle in Patients with Previous Acromegaly
    Julia Szendroedi, Elisabeth Zwettler, Albrecht Ingo Schmid, Marek Chmelík, Giovanni Pacini, Gertrud Kacerovsky-Bielesz, Gerhard Smekal, P. Nowotny, Oswald F Wagner, Christoph Schnack et al. · 2008 · PLoS ONE
85. Gastrointestinal metabolic surgery for the treatment of type 2 diabetes mellitus
    Eng-Hong Pok · 2014 · World Journal of Gastroenterology
86. Ala12 variant of the peroxisome proliferator-activated receptor-γ gene (PPARG) is associated with higher polyunsaturated fat in adipose tissue and attenuates the protective effect of polyunsaturated fat intake on the risk of myocardial infarction
    Edward Ruiz-Narváez, Peter Kraft, Hannia Campos · 2007 · American Journal of Clinical Nutrition
87. Effects of selected bioactive food compounds on human white adipocyte function
    Christel Björk, Uta Wilhelm, Susanne Mandrup, Bjørk Ditlev Larsen, Alessandra Bordoni, Per Hedén, Mikael Rydén, Peter Arner, Jurga Laurencikiene · 2016 · Nutrition & Metabolism
88. Anthropometric Measurements and Diabetes Mellitus: Clues to the “Pathogenic” and “Protective” Potential of Adipose Tissue
    H. Bays, K. Fox, S. Grandy · 2010 · Metabolic Syndrome and Related Disorders
89. From an Apple to a Pear: Moving Fat around for Reversing Insulin Resistance
    Maha Alser, Mohamed A. Elrayess · 2022 · International Journal of Environmental Research and Public Health
90. Gene expression profiling of 3T3-L1 adipocytes exposed to phloretin
    Meryl Hassan, Claire El Yazidi, Christiane Malezet‐Desmoulins, Marie Josèphe Amiot, Alain Margotat · 2009 · The Journal of Nutritional Biochemistry
91. Beneficial effects of rosiglitazone on novel cardiovascular risk factors in patients with Type 2 diabetes mellitus
    Nikolaos P. E. Kadoglou, Fotios S Iliadis, NICKOLETTA A. ANGELOPOULOU, Despina N Perrea, Christos D. Liapis, Miltiadis Alevizos · 2008 · Diabetic Medicine
92. Pathophysiologic Mechanisms Linking Adipose Tissue and Cardiometabolic Risk
    Myriam Zaydee Allende-Vigo · 2010 · Endocrine Practice
93. Association between serum free fatty acid levels and possible related factors in patients with type 2 diabetes mellitus and acute myocardial infarction
    Zhihua Lv, Pei Ma, Wan Hong Luo, Hui Xiong, Lu Han, Siwei Li, Xin Zhou, Jiancheng Tu · 2014 · BMC Cardiovascular Disorders
94. Empagliflozin and linagliptin combination therapy for treatment of patients with type 2 diabetes mellitus
    Curtis L. Triplitt, Carolina Solis‐Herrera, Eugênio Cersósimo, Muhammad A Abdul‐Ghani, Ralph Anthony DeFronzo · 2015 · Expert Opinion on Pharmacotherapy
95. Irbesartan treatment up‐regulates hepatic expression of PPARα and its target genes in obese Koletsky ( fa k / fa k ) rats: a link to amelioration of hypertriglyceridaemia
    Xianglu Rong, Yaxin Li, Ken Ebihara, Mingming Zhao, Toru Kusakabe, Tsutomu Tomita, Michael T. Murray, Kazuwa Nakao · 2010 · British Journal of Pharmacology
96. Myocardial Fatty Acid Metabolism and Lipotoxicity in the Setting of Insulin Resistance
    Bernard P. Kok, David N. Brindley · 2012 · Heart Failure Clinics
97. Chronic noise-exposure exacerbates insulin resistance and promotes the manifestations of the type 2 diabetes in a high-fat diet mouse model
    Lijie Liu, Yi Huang, Cong Fang, Hongyu Zhang, Jingyu Yang, Chuanying Xuan, Fanfan Wang, Haiying Lu, Shuangfeng Cao, Yongfang Wang et al. · 2018 · PLoS ONE
98. β2-adrenergic receptor and UCP3 variants modulate the relationship between age and type 2 diabetes mellitus
    Michele Pinelli, Manuela Giacchetti, Fabio Acquaviva, Sergio Cocozza, Giovanna Donnarumma, Emanuela Lapice, Gabriele Riccardi, Geremia Romano, Olga Vaccaro, Antonella Monticelli · 2006 · BMC Medical Genetics
99. Aquaporin-7 and aquaporin-12 modulate the inflammatory phenotype of endocrine pancreatic beta-cells
    Inês V. da Silva, Carlos Cardoso, Leire Méndez-Giménez, S.P. Camões, Gema Frühbeck, Amaia Rodrı́guez, Joana P. Miranda, Graça Soveral · 2020 · Archives of Biochemistry and Biophysics
100. Melatonin increases intracellular calcium in the liver, muscle, white adipose tissues and pancreas of diabetic obese rats
     Ahmad Agil, Ehab Kotb Elmahallawy, José Manuel Rodríguez-Ferrer, Abdu Adem, Salim M. A. Bastaki, Ibrahim Alabbadi, Y. A. Fino Solano, Miguel Navarro‐Alarcón · 2015 · Food & Function